Alvotech to Report Financial Results for the First Quarter of 2026
Alvotech, a global biotechnology company specializing in biosimilar medicines, announced it will release its first quarter 2026 financial results on May 6, 2026, followed by a webcast and live Q&A session on May 7. The company continues to focus on development and commercialization of biosimilars targeting autoimmune, eye, osteoporosis, respiratory…